Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat
FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat
FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat
Submitted by
admin
on May 6, 2013 - 11:34am
Source:
Marketwatch
News Tags:
FDA
breakthrough therapies
hepatitis C
AbbVie
Headline:
FDA ‘breakthrough’ tab on AbbVie Hepatitis C drug leaves shares flat
Do Not Allow Advertisers to Use My Personal information
